Evaluation of human N-linked glycosylation sites in murine granulocyte-macrophage colony-stimulating factor

Scott W. Altmann, Michael B. Prystowsky

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Nonglycosylated murine and human granulocyte-macrophage colony-stimulating factor have a molecular mass of ∼14.5 kDa predicted from the primary amino acid sequence. The expression of both proteins in COS cells leads to a heterogeneous population of molecules that differ in the degree of glycosylation. Both human and murine molecules contain two N-linked glycosylation sites that are situated in nonhomologous locations along the linear sequence. Despite this difference both proteins show a similar size distribution among the glycosylation variants. These studies analyze the effects of introducing in the murine protein novel N-linked glycosylation sites corresponding to those sites found in the human molecule. A panel of molecules composed of various combinations of human N-linked glycosylation sites in either the presence or the absence of murine N-linked glycosylation was compared. Substitution of a proper human N-linked glycosylation consensus sequence at Asn 24 did not result in N-linked glycosylation, nor was there any considerable effect on bioactivity. Replacement of the N-linked glycosylation consensus sequence at Asn 34 results in glycosylation similar to that found in the human molecule and causes a significant decrease in bioactivity. These data suggest that the position of N-linked glycosylation is critical for maximal bioactivity in a particular species and that the changes in position of these sites in different species probably occurred during evolution in response to changes in their receptors.

Original languageEnglish (US)
Pages (from-to)349-355
Number of pages7
JournalArchives of Biochemistry and Biophysics
Volume293
Issue number2
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Glycosylation
Granulocyte-Macrophage Colony-Stimulating Factor
Bioactivity
Molecules
Consensus Sequence
Proteins
COS Cells
Molecular mass
Amino Acid Sequence
Substitution reactions

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

@article{2fb03105516d41dba1fd5e6c339425bc,
title = "Evaluation of human N-linked glycosylation sites in murine granulocyte-macrophage colony-stimulating factor",
abstract = "Nonglycosylated murine and human granulocyte-macrophage colony-stimulating factor have a molecular mass of ∼14.5 kDa predicted from the primary amino acid sequence. The expression of both proteins in COS cells leads to a heterogeneous population of molecules that differ in the degree of glycosylation. Both human and murine molecules contain two N-linked glycosylation sites that are situated in nonhomologous locations along the linear sequence. Despite this difference both proteins show a similar size distribution among the glycosylation variants. These studies analyze the effects of introducing in the murine protein novel N-linked glycosylation sites corresponding to those sites found in the human molecule. A panel of molecules composed of various combinations of human N-linked glycosylation sites in either the presence or the absence of murine N-linked glycosylation was compared. Substitution of a proper human N-linked glycosylation consensus sequence at Asn 24 did not result in N-linked glycosylation, nor was there any considerable effect on bioactivity. Replacement of the N-linked glycosylation consensus sequence at Asn 34 results in glycosylation similar to that found in the human molecule and causes a significant decrease in bioactivity. These data suggest that the position of N-linked glycosylation is critical for maximal bioactivity in a particular species and that the changes in position of these sites in different species probably occurred during evolution in response to changes in their receptors.",
author = "Altmann, {Scott W.} and Prystowsky, {Michael B.}",
year = "1992",
doi = "10.1016/0003-9861(92)90405-L",
language = "English (US)",
volume = "293",
pages = "349--355",
journal = "Archives of Biochemistry and Biophysics",
issn = "0003-9861",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Evaluation of human N-linked glycosylation sites in murine granulocyte-macrophage colony-stimulating factor

AU - Altmann, Scott W.

AU - Prystowsky, Michael B.

PY - 1992

Y1 - 1992

N2 - Nonglycosylated murine and human granulocyte-macrophage colony-stimulating factor have a molecular mass of ∼14.5 kDa predicted from the primary amino acid sequence. The expression of both proteins in COS cells leads to a heterogeneous population of molecules that differ in the degree of glycosylation. Both human and murine molecules contain two N-linked glycosylation sites that are situated in nonhomologous locations along the linear sequence. Despite this difference both proteins show a similar size distribution among the glycosylation variants. These studies analyze the effects of introducing in the murine protein novel N-linked glycosylation sites corresponding to those sites found in the human molecule. A panel of molecules composed of various combinations of human N-linked glycosylation sites in either the presence or the absence of murine N-linked glycosylation was compared. Substitution of a proper human N-linked glycosylation consensus sequence at Asn 24 did not result in N-linked glycosylation, nor was there any considerable effect on bioactivity. Replacement of the N-linked glycosylation consensus sequence at Asn 34 results in glycosylation similar to that found in the human molecule and causes a significant decrease in bioactivity. These data suggest that the position of N-linked glycosylation is critical for maximal bioactivity in a particular species and that the changes in position of these sites in different species probably occurred during evolution in response to changes in their receptors.

AB - Nonglycosylated murine and human granulocyte-macrophage colony-stimulating factor have a molecular mass of ∼14.5 kDa predicted from the primary amino acid sequence. The expression of both proteins in COS cells leads to a heterogeneous population of molecules that differ in the degree of glycosylation. Both human and murine molecules contain two N-linked glycosylation sites that are situated in nonhomologous locations along the linear sequence. Despite this difference both proteins show a similar size distribution among the glycosylation variants. These studies analyze the effects of introducing in the murine protein novel N-linked glycosylation sites corresponding to those sites found in the human molecule. A panel of molecules composed of various combinations of human N-linked glycosylation sites in either the presence or the absence of murine N-linked glycosylation was compared. Substitution of a proper human N-linked glycosylation consensus sequence at Asn 24 did not result in N-linked glycosylation, nor was there any considerable effect on bioactivity. Replacement of the N-linked glycosylation consensus sequence at Asn 34 results in glycosylation similar to that found in the human molecule and causes a significant decrease in bioactivity. These data suggest that the position of N-linked glycosylation is critical for maximal bioactivity in a particular species and that the changes in position of these sites in different species probably occurred during evolution in response to changes in their receptors.

UR - http://www.scopus.com/inward/record.url?scp=0026603901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026603901&partnerID=8YFLogxK

U2 - 10.1016/0003-9861(92)90405-L

DO - 10.1016/0003-9861(92)90405-L

M3 - Article

VL - 293

SP - 349

EP - 355

JO - Archives of Biochemistry and Biophysics

JF - Archives of Biochemistry and Biophysics

SN - 0003-9861

IS - 2

ER -